Recent advances in gel technologies for topical and transdermal drug delivery

Drug Development and Industrial Pharmacy

Volumn 40, Issue 4, 2014, Pages 433-440

  Rehman, Khurram ^a   Zulfakar, Mohd Hanif ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

Aerogels; Bigels; Emulgels; Hydrogels; Niosomes; Oleogels; Topical; Transdermal drug delivery

Indexed keywords

DRUG CARRIER; NIOSOME; PRONIOSOME; UNCLASSIFIED DRUG;

AEROGEL; AQUEOUS SOLUTION; BIGEL; BIOCOMPATIBILITY; DRUG BIOAVAILABILITY; DRUG DELIVERY DEVICE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; EMULGEL; GEL; HYDROGEL; LIPID BILAYER; MICROEMULSION; ORGANOGEL; PARTICLE SIZE; PATIENT COMPLIANCE; PHYSICAL CHEMISTRY; REVIEW; THERMODYNAMICS; TOPICAL DRUG ADMINISTRATION; TRANSDERMAL DRUG ADMINISTRATION; XEROGEL;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, TOPICAL; DRUG DELIVERY SYSTEMS; GELS; HUMANS; HYDROGELS; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; PHARMACEUTICAL PREPARATIONS; SKIN ABSORPTION; SOLVENTS;

EID: 84896732486     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2013.828219     Document Type: Review

References (100)

1. Lukas L. The epidermal permeability barrier. Anat Embryol 1988; 178:1-13.
2. Peter ME. Structure and function of the stratum corneum permeability barrier. Drug Devlop Res 1988;13:97-105.
3. Michaels A, Chandrasekaran S, Shaw J. Drug permeation through human skin: theory and in vitro experimental measurement. AlChE 1975;21:958-96.
4. Kiyomi W, Takuya H, Kenjirou Y, et al. An insight into the role of barrier related skin proteins. Int J Pharm 2012;427:293-8.
5. Abdallah DJ, Weiss RG. Organogels and low molecular mass organic gelators. Adv Mater 2000;12:1237-47.
6. Allan SH. Hydrogels for biomedical applications. Adv Drug Deliv Rev 2012;64:18-23.
7. Vintiloiu A, Leroux JC. Organogels and their use in drug delivery - a review. J Control Release 2008;125:179-92.
8. Otto W, Drahoslav L. Hydrophilic gels in biologic use. Nature 1960; 185:117-18.
9. Shapiro YE. Structure and dynamics of hydrogels and organogels: an NMR spectroscopy approach. Prog Polym Sci 2011;36: 1184-253.
10. Chang RK, Raw A, Lionberger R, Yu L. Generic development of topical dermatologic products: formulation development, process development, and testing of topical dermatologic products. AAPS J 2013;15:41-52.
11. Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulation. Eur J Pharm Biopharm 2000;50:27-46.
12. Gupta A, Mishra AK, Singh AK, et al. Formulation and evaluation of topical gel of diclofenac sodium using different polymers. Drug Invention Today 2010;5:250-3.
13. Martinez RMA, Julian LVG, Maria MdB, et al. Rheological behavior of gels and meloxicam release. Int J Pharm 2007;333: 17-23.
14. Davide C, Patrick D, Marco R, et al. Semisynthetic resorbable materials from hyaluronan esterification. Biomaterial 1998;19: 2101-27.
15. Mohd CIMA, Naveed A, Nadia H, Ishak A. Synthesis and characterization of thermo- and pH-responsive bacterial cellulose/acrylic acid hydrogels for drug delivery. Carbohydr Polym 2012;88: 465-73.
16. Naryan B, Jonathan G, Miqin Z. Chitosan-based hydrogels for controlled, localized drug delivery. Adv Drug Deliv Rev 2010;62: 83-99.
17. Lee SC, Keun K, Kinam P. Hydrogels for delivery of bioactive agents: a historical perspective. Adv Drug Deliv Rev 2013;65: 17-20.
18. Thomas B, Mieke V, Jorg S, et al. A review of trends and limitations in hydrogel-rapid prototyping for tissue engineering. Biomaterial 2012;33:6020-41.
19. Cho E, Lee JS, Webb K. Formulation and characterization of poloxamine-based hydrogels as tissue sealants. Acta Biomater 2012; 8:2223-32.
20. Sosnik A, Sefton MV. Semi-synthetic collagen/poloxamine matrices for tissue engineering. Biomaterial 2005;26:7425-35.
21. Go DH, Joung YK, Lee SY, et al. Tertronic-oligolactide-heparin hydrogel as a multi-functional scaffold for tissue regeneration. Macromol Biosci 2008;8:1152-60.
22. Suedee R, Bodhibukkana C, Tangthong N, et al. Development of a reservoir-type transedermal enatioselective-controlled delivery system for racemic propranolol using molecularly imprinted polymer composite membrane. J Control Release 2008;129:170-8.
23. Maria DM-O, Carmen A-L, Angel C, Thorstein L. Cyclodextrinbased nanogels for pharmaceutical and biomedical applications. Int J Pharm 2012;428:152-63.
24. Loira PC, Sapin MA, Diab R, et al. Low molecular weight heparin gels, based on nanoparticles for tropical delivery. Int J Pharm 2012; 426:256-62.
25. Xi C, Li-Hua P, Ying-Hui S, et al. Astragaloside IV-loaded nanoparticle-enriched hydrogel induces wound healing and antiscar activity through topical delivery. Int J Pharm 2013;447:171-81.
26. Chang YG, QinJie W, YuJun W, et al. A biodegradable hydrogel system containing curcumin encapsulated in micelles for cutaneous wound healing. Biomaterial 2013;34:6377-87.
27. Choi S, Baek E, Davaa E, et al. Topical treatment of the buccal mucosa and wounded skin in rats with a triamcinolone acetonideloaded hydrogel prepared using an electron beam. Int J Pharm 2013; 447:102-8.
28. Hughes NE, Marangon AG, Wright AJ, et al. Potential food applications of edible oil organogels. Trends Food Sci Tech 2009;20: 47080.
29. Schaink HM, van Malssen KF, Morgado-Alves S, et al. Crystal network for edible oil organogels: possibilities and limitations of the fatty acid and fatty alcohol systems. Food Res Int 2007;40:1185-93.
30. Lupi FR, Garbriele D, Facciolo D, et al. Effect of organogelator and fat source on rheological properties of olive oil-based organogels. Food Res Int 2012;46:177-84.
31. Terech P, Weiss RG. Low molecular mass gelators of organic liquids and properties of their gels. Chem Rev 1997;97:3133-59.
32. Van EJH, Feringa BL. New functional materials based on self assembling organogels: from serendipity towards design. Angew Chem 2000;39:2263-6.
33. Isabel FA, Bahia MF. Evaluation of the physical stability of two oleogels. Int J Pharm 2006;327:73-7.
34. Sara DP, Sonia C, Agnese P, et al. Effect of monoglyceride organogel structure on cod liver oil stability. Food Res Int 2011;44: 2978-83.
35. Rocha JCB, Lopes JD, Mascarenhas MCN, et al. Thermal and rheological properties of organogels formed by sugarcane or candelilla wax in soybean oil. Food Res Int 2013;50:318-23.
36. Toro-Vazquez JF, Morales R, Alvarado ED, et al. Thermal and textural properties of organogels developed by candelilla wax in safflower oil. J Am Oil Chem Soc 2007;84:989-1000.
37. Esposito E, Menegatti E, Cortesi R. Design and chracterization of fenretinide containing organogels. Math Sci Eng C 2013;33:383-9.
38. Kazunori I, Sumizawa T, Miyazaki M, Kakemi M. Characterization of organogel as a novel oral controlled release formulation for lipophilic compounds. Int J Pharm 2010;388:123-8.
39. Dassanayake LSK, Kodali DR, Ueno S. Formation of oleogels based on edible lipid materials. Curr Opin Colloid Interface Sci 2011;16: 432-9.
40. Sinha VR, Maninder PK. Permeation enhancers for transdermal drug delivery. Drug Dev Ind Pharm 2000;26:1131-40.
41. Sushi lR, Santosh SB, Vaibhav U, et al. Lecithin organogel: a unique micellar system for the delivery of bioactive agents in the treatment of skin aging. Acta Pharmaceut Sin B 2012;2:8-15.
42. Rajiv K, Om PK. Lecithin organogel as a potential phospholipidstructured system for topical drug delivery: a review. AAPS PharmaSciTech 2005;6:298-310.
43. Shaikh IM, Jadhav KR, Gide PS, et al. Topical delivery of aceclofenac from lecithin organogels: preformulation study. Curr Drug Deliv 2006;3:417-27.
44. Willimann H, Walde P, Luisi L, et al. Lecithin organogels as matrix for transdermal transport drugs. J Pharm Sci 1992;81:871-4.
45. Masotti A, Vicennati P, Alisi A, et al. Novel Tween 20 derivatives enable the formation of efficient pH-sensitive drug delivery vehicles for human heptaoblastoma. Bioorg Med Chem Lett 2010;2:3021-5.
46. Marianecci C, Carafa M, Marizo LD, et al. A new vesicle loaded hydrogel system suitable for topical applications: preparation and Characterization. J Pharm Pharmaceutic Sci 2011;14:336-46.
47. El-Laithy HM, Shoukry O, Mahran LG. Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm 2011;77:43-55.
48. Gannu PK, Pogaku R. Nonionic surfactant vesicular systems for effective drug delivery-an overview. Acta Pharmaceut Sin B 2011;1: 208-19.
49. Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 2001;228:43-52.
50. Aranya M, Charinya C, Worapaka M, Jiradej M. Transdermal absorption enhancement of papin loaded in elastic niosomes incorporated in gel for scar treatment. Eur J Pharm Sci 2012; 48;474-83.
51. Gonnet M, Lethuaut L, Boury F. New trends in encapsulation of liposoluble vitamins. J Control Release 2010;146:276-90.
52. Gupta PN, Mishra V, Rawat A, et al. Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study. Int J Pharm 2005;293:73-82.
53. Aranya M, Warintorn R, Masahiko A, et al. Transfollicular enhancement of gel containing cationic niosomes loaded with unsaturated fatty acids in rice (Oryza sativa) bran semi-purified fraction. Eur J Pharm Biopharm 2012;81:303-13.
54. Bangham AD, Standish MM, Walkins JC. Diffusion of univalent ions across the lamellae of swollen phopholipids. J Mol Biol 1965; 13:238-52.
55. Maria M, Chiara S, Donatella V, et al. Niosomes as carrier for tretinoin. I. Preparation and properties. Int J Pharm 2002;234: 237-48.
56. Biswal S, Murthy P, Sahu J, et al. Vesicles of non ionic surfactants (niosomes) and drug delivery potential. Int J Pharm Sci Nanotech 2008;1:1-8.
57. Jia YF, Song YY, Pao CW, et al. In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 2001;215:91-9.
58. Mahale NB, Thakkar PD, Mali RG, et al. Niosomes: Novel sustained release nonionic stable vesicular systems - an overview. Adv Colloid Interface Sci 2012;183-4:46-54.
59. Uchegbu IF, Florence AT. Non-ionic surfactant vesicles (niosomes): physical and pharmaceutical chemistry. Adv Coll Interf Sci 1995;58: 1-55.
60. Kumar K, Rai AK. Proniosomal formulation of curcumin having anti-inflammatory and anti-arthritic activity in different experimental animal models. Pharmazie 2012;67:852-7.
61. Sankar V, Praveen C, Prasanth KG, et al. Formulation and evaluation of a proniosome hydrocortisone gel in comparison with commercial cream. Pharmazie 2009;64:731-4.
62. Ammar HO, Ghorab M, El-Nahhas SA, Higazy IM. Proniosomes as a carrier system for transdermal delivery of tenoxicam. Int J Pharm 2011;405:142-52.
63. Ibrahim AA, Bosela AA, Ahmed SM, Mahrous GM. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm 2005;59:485-90.
64. Frfkjaer S, Hjorth E, Writis O. Stability testing of liposomes during storage. In: Gregoriadis G, ed. Liposome technology. Florida: CRC Press; 1984:235-45.
65. Hatziantoniou S, Rallis M, Demetzos C, Papaioannou GT. Pharmaceutical activity of natural lipids on a skin barrier disruption model. Pharmacol Res 2000;42:55-9.
66. Zhang XL, Zhao R, Qian W. Preparation of an emulgel for treatment of aphthous ulcer on basis of carbomers. Chin Pharm J 1995;30: 417-18.
67. Rahmani-Neishaboor E, Jallili R, Hartwell R, et al. Topical application of a film-forming emulgel dressing that controls the release of stratifin and acetylsalicylic acid and improves/prevents hypertrophic scarring. Wound Repair Regen 2013;21:55-65.
68. Mohamed MI. Optimization of chlorphenesin emulgel formulation. AAPS J 2004;6:81-7.
69. Khullar R, Kumar D, Seth N, Saini S. Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi Pharm J 2012; 20:63-7.
70. Stanos SP. Topical agents for the management of musculoskeletal pain. J Pain Symptom Manage 2007;33:342-55.
71. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev 2012;64:175-93.
72. Lee EA, Balakrishnan P, Song CK, et al. Microemulsion-based hydrogel formulation of Itraconazole for topical delivery. J Pharm Invest 2010;40:305-11.
73. Dreher F, Walde P, Walther P, Wehrli E. Interaction of a lecithin microemulsion gel with human stratum corneum and its effect on transdermal transport. J Control Release 1997;45:131-40.
74. Perioli L, Pagano C, Mazzitelli S, et al. Rheological and functional characterization of new antiinflammatory delivery systems designed for buccal administration. Int J Pharm 2008;356:19-28.
75. Weiwei Z, Chenyu G, Aihua Y, et al. Microemulsion-based hydrogel formulation of penciclovir for topical delivery. Int J Pharm 2009; 378:152-8.
76. Park US, Theraskin M, Antonio G, et al. Assessment of a new skin brightening emulgel containing glycolic acid, lactic acid, kojic acid, arbutin, and UVA/UVB filters in females with melasma. J Am Acad Dermatol 2012;66:AB178.
77. Feng G, Xiong Y, Wang H, Yang Y. Gelation of microemulsions and release behaviour of sodium salicylate from gelled microemulsion. Eur J Pharm Biopharm 2009;71:297-302.
78. Gannu R, Palem CR, Yamsani VV, et al. Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: formulation optimiztion, ex vivo and in vivo characterization. Int J Pharm 2010; 388:231-41.
79. Senhao L, Donggin Q. Preparation and in vitro evaluation of an ilomastat microemulsion gel by a self-microemulsifying system. Pharmazie 2012;67:156-60.
80. Barot BS, Parejiya PB, Patel HK, et al. Microemulsion-based gel of terbinafine for the treatment of onychomycosis: optimization of formulation using D-optimal design. AAPS PharmaSciTech 2012; 13:184-92.
81. Boonme P, Suksawad N, Songkro S. Characterization and release kinetics of nicotinamide microemulsion-based gels. J Cosmet Sci 2012;63:397-406.
82. Chudasama A, Patel V, Nivsarkar M, et al. Investigation of microemulsion system for transdermal delivery of itraconazole. J Adv Pharm Technol Res 2011;2:30-8.
83. Luo M, Shen Q, Chen J. Transdermal delivery of paeonol using cubic gel and microemulsion gel. Int J Nanomedicine 2011;6: 1603-10.
84. Araujo LMPC, Thomazine JA, Lopez RFV. Development of microemulsions to topically delivery 5-aminolevulinic acid in photodynamic therapy. Eur J Pharm Biopharm 2010;75:48-5.
85. Azeem A, Talegaonkar S, Negi LM, et al. Oil based nanocarrier system for transdermal delivery of ropinirole: a mechanistic, pharmacokinetic and biochemical investigation. Int J Pharm 2012; 422:436-44.
86. Kantaria S, Rees GD, Lawrence MJ. Gelatin-stabilised microemulsion based organogels: rheology and application in iontophoretic transdermal drug delivery. J Control Release 1999;60:355-65.
87. Rhee GJ, Woo JS, Hwang SJ, et al. Topical oleo-hydrogel preparation of ketoprofen with enhanced skin permeability. Drug Dev Ind Pharm 1999;25:717-26.
88. Almedia IF, Fernandes AR, Fernandes MR, et al. Moisturizing effect of oleogel/hydrogel mixtures. Pharm Dev Technol 2008;13: 487-94.
89. Jibry N, Heenan RK, Murdan S. Amphiphilogels for drug delivery, formulation and characterization. Pharm Res 2004;21:1851-61.
90. Uros M, Aliaz G, Marian B, Odon P. Novel hybrid silica xerogels for stabilization and controlled release of drug. Int J Pharm 2007;330: 164-74.
91. Guenther U, Smirnova I, Neubert RHH. Hydrophilic Silica aerogels as dermal drug delivery systems- Dithranol as a model drug. Eur J Pharm Biopharm 2008;69:935-42.
92. Alnaief M, Antonyuk S, Hentzschel CM, et al. A novel process of coating of silica aerogel microspheres for controlled drug release applications. Microporous Mesoporous Mater 2012;160: 167-73.
93. Garcia-Gonzalez CA, Uy JJ, Alnaief M, Smirnova I. Preparation of tailor made starch based aerogel microsphers by the emulsiongeltation method. Carbohydr Polym 2012;88:1378-86.
94. Smirnova I, Tuerk M, Wischumerski R, Wahl AM. Comparison of different methods for enhancing the dissolution rate of poorly soluble drugs: case of griseofulvin. Eng Life Sci 2005;5:277-80.
95. Alnaief M, Alzaitoun M, Garcia Gonalez CA, Smirnova I. Preparation of biodegradable nanoporous microspherical aerogel based on alginate. Carbohydr Polym 2011;84:1011-18.
96. Cheng Y, Lingbin L, Wuyuan Z, et al. Reinforce low density alginate based aerogels: preparation, hydrophobic modification and characterization. Carbohydr Polym 2012;88:1093-9.
97. Ollio A, Ollio J. The preparation of lignocellulosic aerogels from ionic liquid solutions. Carbohydr Polym 2009;75:125-9.
98. Garcia GCA, Alnaief M, Smirnova I. Polysaccharide based aerogels-promising biodegradable carriers for drug delivery systems. Carbohydr Polym 2011;86:1425-38.
99. Cardea S, Pisanti P, Reverchon E. Generation of chitosan nanoporous structure for tissue engineering applications using a supercritical fluid assisted process. J Supercrit Fluids 2010;54:290-5.
100. Anja V, Zeljko K, Zoran N. Preparation of multi-membrane alginate aerogels used for drug delivery. J Supercrit Fluids 2013;79: 209-15.